Resonant Publishes Groundbreaking Alzheimer’s Disease Research With the Potential to Revolutionize Neurodegenerative Diagnostics

Alzheimer’s disease, a devastating neurodegenerative disorder, poses formidable challenges in both diagnosis and treatment. Its pre-symptomatic detection remains elusive, and the current diagnostic approach primarily relies on documenting mental decline, leading to late-stage diagnosis when severe brain damage has already taken place. Compounding the issue, the disease’s gradual progression involves years of elevated neuronal cell death before visible symptoms emerge, with approximately 60 percent of neurons already lost by the time symptoms become apparent (1). Consequently, therapeutic interventions aiming to prevent the disease are rendered ineffective once symptoms manifest. Existing treatments offer modest relief, providing patients with only a few additional years of quality life before cognitive function significantly declines. However, early pre-symptomatic diagnosis has the potential to revolutionize disease management, allowing interventions that could halt the disease’s progression altogether, significantly improving patient outcomes.

Read full article on Neurology

Read full article on Frontiers